You are here: Industry Insights > breast

News List

Blood test predicts effectiveness of palbociclib in breast cancer patients europeanpharmaceuticalreview
April 25, 2019
A new study has found a blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests…
Puma licences breast cancer therapy to Pierre Fabre in Europe pharmaceutical-technology
April 23, 2019
Puma licences breast cancer therapy to Pierre Fabre in Europe.
Cardiac monitoring for high-risk breast cancer patients ‘should be prioritised’ europeanpharmaceuticalreview
April 19, 2019
Cardiac monitoring of high-risk breast cancer patients should be prioritised, after research revealed low rates of heart monitoring seen in the patients receiving trastuzumab.
Some Patients With Imminently Fatal Cancer Undergo Treatment drugs
April 18, 2019
Some patients with imminently fatal de novo metastatic cancer undergo treatment.
Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Scale b3cnewswire
April 17, 2019
Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Scale.
Palbociclib improves patients’ survival in metastatic breast cancer europeanpharmaceuticalreview
October 31, 2018
A Phase III clinical trial has shown that a combination of palbociclib and fulvestrant leads to a longer survival for HR-positive breast cancer…
Pfizer's Innovative drug IBRANCE gets China approval .biospectrumasia
October 11, 2018
World's First Kinase 4/6 (CDK 4/6) Inhibitor and Only Innovative Breakthrough Therapy for Advanced Breast Cancer in China over Past Ten Years

Previous page 1 2 3 4 5 6 Next page